Biotech News

U.S. stock futures extended a bearish tone in the wake of gross-domestic-product data that showed the U.S. economy lost momentum in the second quarter.

Required fields are marked with an asterisk The information you provide will be used only to send the requested e-mail and will not be used to send any other e-mail communications.

In this May 12, 2009 file photo, Sanofi CEO, Chris Viehbacher, delivers his speech during the launch of Sanofi Pasteur's new plant, Sanofi's 11th vaccine production plant in the world.

Drugmaker Merck & Co. posts a 52 percent drop in second-quarter net income, due to higher costs for sales, administration and restructuring and sharply lower income from partnerships.

Investment firm Jana Partners LLC on Thursday urged shareholders of Charles River Laboratories International Inc.

Germany's Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.

Amgen Inc. reported slightly lower earnings late Thursday, due to various charges and decreased sales of two of its leading products, Enbrel and Aranesp.

SACRAMENTO, Calif. a " California is pressuring Bristol-Myers Squibb to reduce the cost of a key AIDS medication.The drug giant's Reyataz is one of the most common drugs to treat AIDS patients, and it's the most costly with an average wholesale price of $13,046 a year.State Controller John Chiang wrote Bristol-Myers Squibb this month to urge the ...

European stock markets rose Thursday after another batch of positive earnings and further evidence that Europe's economy is recovering faster than previously expected.

By JANE WARDELL AstraZeneca PLC posted a 22 percent rise in second quarter net profit on Thursday as it also revealed that a key new drug - its blood thinner Brilinta - has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration.The Anglo-Swedish drugmaker raised its full-year earnings forecast after reporting a ...

German drug and chemical maker Merck KGaA says its second-quarter earnings were up 69 percent - led higher by strong increases in revenue at its liquid crystals and chemicals businesses.

Safeguards to protect patients from risky drugs should have less paperwork and more consistency, drugmakers and pharmacy representatives said this week during a U.S. Food and Drug Administration meeting.

GlaxoSmithKline may have shot itself in the foot with its new bonus structure for pharmaceutical sales reps .

The man in the yellow hoodie robbed Gordon's pharmacy in Canyonville on July 15, according to witnesses.

GTC Biotherapeutics , the Framingham-based drug manufacturer, moved closer to profitability in the second quarter, but still registered a $300,000 loss on $4.9 million in revenues.

Broadcom Corp. posted a climb in quarterly earnings late Tuesday, but shares of the communications chip maker weren't able to gain traction during the session.

Collier County Commission Chambers filled to capacity Tuesday for the commission meeting concerning Jackson Laboratory.

Iconix Brand Group Inc., a brand licensing company, said Tuesday it is promoting Yehuda Shmidman to the position of chief operating officer.

Genentech has agreed to buy a compound that may help in treating inflammatory and autoimmune diseases.

Merck & Co. and Sanofi-Aventis SA said Tuesday Raul Kohan will be the CEO of their planned animal health joint venture, which is expected to be the world's largest maker of pet and livestock medicines and vaccines.